comparemela.com
Latest Breaking News On - Santersu nucleocapture - Page 1 : comparemela.com
Aethlon Inks Materials Transfer Deal For Santersus' NucleoCapture And HemoNucleoCapture Devices
(RTTNews) - Medical therapeutic company Aethlon Medical, Inc. (AEMD) announced Wednesday that it entered into a Materials Transfer Agreement (MTA).
London
City-of
United-kingdom
Zurich
Züsz
Switzerland
Santersu-nucleocapture
Aethlon-hemopurifier
Aethlon-medical-inc
Aethlon-medical
Materials-transfer-agreement
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
/PRNewswire/ Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening.
Switzerland
London
City-of
United-kingdom
Zurich
Züsz
Swiss
James-frakes
Susan-noonan
Santersu-nucleocapture
Aethlon-hemopurifier
Scott-maguire
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Enters Into Materials Transfer Agreement for Santersus AG s NucleoCapture and HemoNucleoCapture Devices
Switzerland
London
City-of
United-kingdom
Zurich
Züsz
Swiss
James-frakes
Santersu-nucleocapture
Scott-maguire
Jim-frakes
Aethlon-hemopurifier
VolitionRx Taking on Nucleosome-Focused Dx for Human Cancers After Canine Cancer Screening Test
The firm is working with MD Anderson Cancer Center to show that its NETosis test can predict which cancer patients are at risk for sepsis.
Nevada
United-states
Switzerland
Swiss
Santersu-nucleocapture
Jake-micallef
Drug-administration
Md-anderson-cancer-center
Cancer-center
Diagnostic-oncology
vimarsana © 2020. All Rights Reserved.